Inventor · disambiguated record
Heike Neumann
Also filed as: NEUMANN HEIKE
2 granted patents·4 pending applications·0 citations·filing 2013–2021
22Inventor score
Top patents by PatentIndex Score
6 records- 0146US2023219952A1Process for preparing methyl {4,6-diamino-2-[5-fluoro-1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridin-3 -yl]pyrimidin-5-yl} carbamateADVERIO PHARMA GMBH·Filed 2021·Application pending·0 cites
- 0244US2015125527A1Pharmaceutical administration forms comprising 5-chloro-n-(methyl)-2-thiophenecarboxamideBayer Pharma AG·Filed 2013·Application pending·0 cites
- 0343US2014010876A1Pharmaceutical administration forms comprising 5-chloro-n-(methyl)-2-thiophenecarboxamideBayer Pharma AG·Filed 2013·Application pending·0 cites
- 0442US2023067593A1Nanoformulations of methyl {4,6-diamino-2-[5-fluoro-1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridin-3 -yl]pyrimidin-5-yl} carbamateADVERIO PHARMA GMBH·Filed 2021·Application pending·0 cites
- 0540US9827198B2Pharmaceutical dosage forms comprising sodium-1-[6-(morpholin-4-yl)pyrimidin-4-yl]-4-(1H-1,2,3-triazol-1-yl)-1H-pyrazol-5-olateBayer Pharma AG·Filed 2014·Granted Nov 28, 2017·0 cites·12 claims
- 0638US12172996B2Methyl {4,6-diamino-2-[5-fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}carbamate active compound product having improved properties, production and formulation thereofADVERIO PHARMA GMBH·Filed 2019·Granted Dec 24, 2024·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Heike Neumann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →